Using in vitro as well as in vivo model systems we demonstrate the importance of BCL9L for the progression of pancreatic cancer and propose a novel, so far unknown functional role of BCL9L in the regulation of EMT. This evidence concerns the gene BCL9L and pancreatic neoplasm.